Prostate cancer is a type of cancer that affects men. It used to be common only in men over 60, but that's changing. Doctors ...
LOS ANGELES (Reuters) - A clinical trial of Amgen Inc's bone drug, Xgeva, found that it can significantly delay the time it takes for prostate cancer to cause bone pain -- a finding the company ...